✦ LIBER ✦

Discovery of N -(2-Aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an Orally Active Histone Deacetylase Inhibitor

✍ Scribed by Zhou, Nancy; Moradei, Oscar; Raeppel, Stephane; Leit, Silvana; Frechette, Sylvie; Gaudette, Frederic; Paquin, Isabelle; Bernstein, Naomy; Bouchain, Giliane; Vaisburg, Arkadii; Jin, Zhiyun; Gillespie, Jeff; Wang, James; Fournel, Marielle; Yan, Pu T.; Trachy-Bourget, Marie-Claude; Kalita, Ann; Lu, Aihua; Rahil, Jubrail; MacLeod, A. Robert; Li, Zuomei; Besterman, Jeffrey M.; Delorme, Daniel

Book ID: 126925947
Publisher: American Chemical Society
Year: 2008
Tongue: English
Weight: 156 KB
Volume: 51
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm800251w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of 4-{4-[3-(Pyridin-2-yl)-1 H

Discovery of 4-{4-[3-(Pyridin-2-yl)-1 H -pyrazol-4-yl]pyridin-2-yl}- N -(tetrahydro-2 H - pyran-4-yl)benzamide (GW788388): A Potent, Selective, and Orally Active Transforming Growth Factor-β Type I Receptor Inhibitor

✍ Gellibert, Françoise; de Gouville, Anne-Charlotte; Woolven, James; Mathews, Neil 📂 Article 📅 2006 🏛 American Chemical Society 🌐 English ⚖ 561 KB

Histone deacetylase inhibitors FK228, N-

Histone deacetylase inhibitors FK228, N-(2-aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl)amino- methyl]benzamide and m-carboxycinnamic acid bis-hydroxamide augment radiation-induced cell death in gastrointestinal adenocarcinoma cells

✍ Yubin Zhang; Masaaki Adachi; Xudong Zhao; Rina Kawamura; Kohzoh Imai 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 466 KB

## Abstract HDAC inhibitors induce histone hyperacetylation by a relative increase of histone acetyltransferase activity. Histone hyperacetylation may affect chromatin structure and susceptibility to DNA‐damaging stress, such as IR. We here investigate whether these inhibitors can radiosensitize hu

N -Hydroxy-3-phenyl-2-propenamides as No

N -Hydroxy-3-phenyl-2-propenamides as Novel Inhibitors of Human Histone Deacetylase with in Vivo Antitumor Activity: Discovery of (2 E )- N -Hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1 H -indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824)

✍ Remiszewski, Stacy W.; Sambucetti, Lidia C.; Bair, Kenneth W.; Bontempo, John; C 📂 Article 📅 2003 🏛 American Chemical Society 🌐 English ⚖ 284 KB

Discovery of a Potent, Selective, and Or

Discovery of a Potent, Selective, and Orally Bioavailable c-Met Inhibitor: 1-(2-Hydroxy-2-methylpropyl)- N -(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1 H -pyrazole-4-carboxamide (AMG 458)

✍ Liu, Longbin; Siegmund, Aaron; Xi, Ning; Kaplan-Lefko, Paula; Rex, Karen; Chen, 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 191 KB

Discovery of N-[2-[5-[Amino(imino)methyl

Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3,5-difluoro- 6-[3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylglycine (ZK-807834): A Potent, Selective, and Orally Active Inhibitor of the Blood Coagulation Enzyme Factor Xa1

✍ Phillips, Gary B.; Buckman, Brad O.; Davey, David D.; Eagen, Keith A.; Guilford, 📂 Article 📅 1998 🏛 American Chemical Society 🌐 English ⚖ 178 KB

ChemInform Abstract: Discovery of N-[2-[

ChemInform Abstract: Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3,5-difluoro-6- [3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl] -N-methylglycine (ZK-807834): A Potent, Selective, and Orally Active Inhibitor of the Blood Coagulation Enzyme Factor Xa.

✍ M. M. MORRISSEY; ET AL. ET AL. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 33 KB 👁 1 views